Authors:
Eid, JE
Brunner, A
Cummings, KB
Weiss, RE
Goodin, S
Aisner, J
Todd, M
DiPaola, RS
Citation: Je. Eid et al., Effect of P-30 protein and tamoxifen on transforming growth factor-beta 1 in patients with rising prostate specific antigen, UROL ONCOL, 6(6), 2001, pp. 243-247
Authors:
DiPaola, RS
Chenven, ES
Shih, WJ
Lin, Y
Amenta, P
Goodin, S
Shumate, A
Capanna, T
Cardiella, M
Cummings, KB
Aisner, J
Todd, MB
Citation: Rs. Dipaola et al., Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma, CANCER, 92(8), 2001, pp. 2065-2071
Authors:
Loehrer, PJ
Jiroutek, M
Aisner, S
Aisner, J
Green, M
Thomas, CR
Livingston, R
Johnson, DH
Citation: Pj. Loehrer et al., Combined etoposide, ifosfamide, and cisplatin in the treatment of patientswith advanced thymoma and thymic carcinoma - An intergroup trial, CANCER, 91(11), 2001, pp. 2010-2015
Authors:
Kaufman, D
Raghavan, D
Carducci, M
Levine, EG
Murphy, B
Aisner, J
Kuzel, T
Nicol, S
Oh, W
Stadler, W
Citation: D. Kaufman et al., Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer, J CL ONCOL, 18(9), 2000, pp. 1921-1927
Authors:
Vogelzang, NJ
Herndon, JE
Miller, A
Strauss, G
Clamon, G
Stewart, FM
Aisner, J
Lyss, A
Cooper, MR
Suzuki, Y
Green, MR
Citation: Nj. Vogelzang et al., High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase IIstudy 9234, ANN ONCOL, 10(5), 1999, pp. 597-600
Authors:
Belani, CP
Kearns, CM
Zuhowski, EG
Erkmen, K
Hiponia, D
Zacharski, D
Engstrom, C
Ramanathan, RK
Capozzoli, MJ
Aisner, J
Egorin, MJ
Citation: Cp. Belani et al., Phase I trial, including pharmacokinetic and pharmacodynamic correlations,of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer, J CL ONCOL, 17(2), 1999, pp. 676-684
Authors:
Abrams, J
Aisner, J
Cirrincione, C
Berry, DA
Muss, HB
Cooper, MR
Henderson, IC
Panasci, L
Kirshner, J
Ellerton, J
Norton, L
Citation: J. Abrams et al., Dose-response trial of megestrol acetate in advanced breast cancer: Cancerand leukemia group B phase III study 8741, J CL ONCOL, 17(1), 1999, pp. 64-73
Authors:
Auperin, A
Arriagada, R
Pignon, JP
Le Pechoux, C
Gregor, A
Stephens, RJ
Kristjansen, PEG
Johnson, BE
Ueoka, H
Wagner, H
Aisner, J
Citation: A. Auperin et al., Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission, N ENG J MED, 341(7), 1999, pp. 476-484